Advanced services

Lateral Flow Test Distribution Service


New Medicine Service (NMS)

All contractors will be aware that the NMS commenced on 1st October 2011, and was the fourth Advanced Service added to the contract. The service is supported by a maximum investment of £55 million per annum in 2011/12 and 2012/13. The aim of the service is to provide support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is initially focused on particular patient groups and conditions. The added benefits are seen in reduced medicine waste as well as reduced hospital admissions due to ADRs.

The NMS is a time-limited service commissioned until March 2013; it will continue* beyond this time if all parties agree that the service has provided demonstrable value to the NHS. The figures, collected through PSNC’s PharmOutcomes, covered NMS interventions to more than 224,000 patients from the service’s launch on October 1, 2011 to September 30, 2012. It revealed that 32 per cent of non-adherent patients became more adherent to their medication following NMS interventions.  *Extended to end 2013. Please see for updates.

NMS Resources

NMS Crib Sheet for Anticoagulants

NPA: NMS Support pack


CPPE : NMS Video Wall

Medicine Use Reviews (MUR)

It’s never too late to get going with the MUR service and with NMS, and start claiming your service payment. Pharmacists wishing to provide this service will need to be accredited to do so.  A competency framework has been developed for the assessment of pharmacists providing the MUR service. There are a number of providers who run courses and/or competency assessments for pharmacists to get accredited to enable them to carry out MURs.  These include:

NHS England have produced a new policy regarding Conducting Medicines Use Reviews (mainly focused on Domiciliary MURs, April 2015).

If you need support with MURs please contact the LPC.


Inhaled Corticosteroids (ICS)  High Dose Steroids MUR review

Bishosphonates– Bone Health

Methadone Plus –  Safe Storage Risk Assessment

Statins –  (MHRA update Oct 2012)

MUR Crib Sheet for Anticoagulants (June 2015)



The C&D MUR Zone is your one-stop resource to get the most out of medicines use reviews, including the three target groups covered in targeted MURs. Categorised by both drug and condition, the zone is an essential library, covering common therapies, key counselling points and lifestyle advice.

NPA: Dr Duncan Petty MUR Training– Long distance Training  Manual

The National Prescribing Centre has produced useful sets of e-learning resources that support organisations and prescribers/contractors in making good clinical decisions and obtaining good therapeutic information. The key therapeutic topics can be found at:

The topics cover a number of useful areas including NSAIDS, insulins, hypoglycaemics, inhaled corticosteroids and others that will be useful in discussions with clinical commissioners and patients undergoing NMS or MURs. QIPP information and external links to useful articles are listed in the menu on the left hand side of the web pages.